Click for best price
Melioidosis Diagnostic Market Size, Share 2024
Melioidosis, also called as Whitmore's Disease, is an infectious disease caused by the bacteria Burkholderia pseudomallei. Melioidosis infection usually affects the lungs and is diagnosed by blood, urine, saliva, or skin lesion examination. Melioidosis bacteria are present in polluted water and soil, and they propagate by direct contact with the contaminated source to humans and animals.
This report aims to provide a comprehensive presentation of the global market for Melioidosis Diagnostic, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Melioidosis Diagnostic. This report contains market size and forecasts of Melioidosis Diagnostic in global, including the following market information:
Global Melioidosis Diagnostic Market Revenue, 2019-2024, 2025-2030, ($ millions)
Global top five companies in 2023 (%)
The global Melioidosis Diagnostic market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2023, While China is to reach $ Million.
Bacterial culture test Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Melioidosis Diagnostic include Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc, PerkinElmer Inc., InBios International, Inc., Mediven and Cell Signaling Technology, Inc, etc. in 2023, the global top five players have a share approximately % in terms of revenue.
We surveyed the Melioidosis Diagnostic companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Melioidosis Diagnostic Market, by Type, 2019-2024, 2025-2030 ($ millions)
Global Melioidosis Diagnostic Market Segment Percentages, by Type, 2023 (%)
Bacterial culture test
Latex fixation test
Hemagglutination assay
Immunofluorescence
Matrix-assisted laser desorption/ionization
Direct fluorescent antibody test
Other Tests
Global Melioidosis Diagnostic Market, by Application, 2019-2024, 2025-2030 ($ millions)
Global Melioidosis Diagnostic Market Segment Percentages, by Application, 2023 (%)
Research laboratories
Hospitals
Academic institutions
Global Melioidosis Diagnostic Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions)
Global Melioidosis Diagnostic Market Segment Percentages, By Region and Country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Melioidosis Diagnostic revenues in global market, 2019-2024 (estimated), ($ millions)
Key companies Melioidosis Diagnostic revenues share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
Thermo Fisher Scientific, Inc.
Bio-Rad Laboratories, Inc
PerkinElmer Inc.
InBios International, Inc.
Mediven
Cell Signaling Technology, Inc
Outline of Major Chapters:
Chapter 1: Introduces the definition of Melioidosis Diagnostic, market overview.
Chapter 2: Global Melioidosis Diagnostic market size in revenue.
Chapter 3: Detailed analysis of Melioidosis Diagnostic company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Melioidosis Diagnostic in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Melioidosis Diagnostic Market, Global Outlook and Forecast 2024-2030 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2023 |
| Forecast Year |
2031 |
| Number of Pages |
67 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Melioidosis Diagnostic Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Melioidosis Diagnostic Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Melioidosis Diagnostic Overall Market Size
2.1 Global Melioidosis Diagnostic Market Size: 2023 VS 2030
2.2 Global Melioidosis Diagnostic Market Size, Prospects & Forecasts: 2019-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Melioidosis Diagnostic Players in Global Market
3.2 Top Global Melioidosis Diagnostic Companies Ranked by Revenue
3.3 Global Melioidosis Diagnostic Revenue by Companies
3.4 Top 3 and Top 5 Melioidosis Diagnostic Companies in Global Market, by Revenue in 2023
3.5 Global Companies Melioidosis Diagnostic Product Type
3.6 Tier 1, Tier 2 and Tier 3 Melioidosis Diagnostic Players in Global Market
3.6.1 List of Global Tier 1 Melioidosis Diagnostic Companies
3.6.2 List of Global Tier 2 and Tier 3 Melioidosis Diagnostic Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Melioidosis Diagnostic Market Size Markets, 2023 & 2030
4.1.2 Bacterial culture test
4.1.3 Latex fixation test
4.1.4 Hemagglutination assay
4.1.5 Immunofluorescence
4.1.6 Matrix-assisted laser desorption/ionization
4.1.7 Direct fluorescent antibody test
4.1.8 Other Tests
4.2 By Type - Global Melioidosis Diagnostic Revenue & Forecasts
4.2.1 By Type - Global Melioidosis Diagnostic Revenue, 2019-2024
4.2.2 By Type - Global Melioidosis Diagnostic Revenue, 2025-2030
4.2.3 By Type - Global Melioidosis Diagnostic Revenue Market Share, 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Melioidosis Diagnostic Market Size, 2023 & 2030
5.1.2 Research laboratories
5.1.3 Hospitals
5.1.4 Academic institutions
5.2 By Application - Global Melioidosis Diagnostic Revenue & Forecasts
5.2.1 By Application - Global Melioidosis Diagnostic Revenue, 2019-2024
5.2.2 By Application - Global Melioidosis Diagnostic Revenue, 2025-2030
5.2.3 By Application - Global Melioidosis Diagnostic Revenue Market Share, 2019-2030
6 Sights by Region
6.1 By Region - Global Melioidosis Diagnostic Market Size, 2023 & 2030
6.2 By Region - Global Melioidosis Diagnostic Revenue & Forecasts
6.2.1 By Region - Global Melioidosis Diagnostic Revenue, 2019-2024
6.2.2 By Region - Global Melioidosis Diagnostic Revenue, 2025-2030
6.2.3 By Region - Global Melioidosis Diagnostic Revenue Market Share, 2019-2030
6.3 North America
6.3.1 By Country - North America Melioidosis Diagnostic Revenue, 2019-2030
6.3.2 US Melioidosis Diagnostic Market Size, 2019-2030
6.3.3 Canada Melioidosis Diagnostic Market Size, 2019-2030
6.3.4 Mexico Melioidosis Diagnostic Market Size, 2019-2030
6.4 Europe
6.4.1 By Country - Europe Melioidosis Diagnostic Revenue, 2019-2030
6.4.2 Germany Melioidosis Diagnostic Market Size, 2019-2030
6.4.3 France Melioidosis Diagnostic Market Size, 2019-2030
6.4.4 U.K. Melioidosis Diagnostic Market Size, 2019-2030
6.4.5 Italy Melioidosis Diagnostic Market Size, 2019-2030
6.4.6 Russia Melioidosis Diagnostic Market Size, 2019-2030
6.4.7 Nordic Countries Melioidosis Diagnostic Market Size, 2019-2030
6.4.8 Benelux Melioidosis Diagnostic Market Size, 2019-2030
6.5 Asia
6.5.1 By Region - Asia Melioidosis Diagnostic Revenue, 2019-2030
6.5.2 China Melioidosis Diagnostic Market Size, 2019-2030
6.5.3 Japan Melioidosis Diagnostic Market Size, 2019-2030
6.5.4 South Korea Melioidosis Diagnostic Market Size, 2019-2030
6.5.5 Southeast Asia Melioidosis Diagnostic Market Size, 2019-2030
6.5.6 India Melioidosis Diagnostic Market Size, 2019-2030
6.6 South America
6.6.1 By Country - South America Melioidosis Diagnostic Revenue, 2019-2030
6.6.2 Brazil Melioidosis Diagnostic Market Size, 2019-2030
6.6.3 Argentina Melioidosis Diagnostic Market Size, 2019-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Melioidosis Diagnostic Revenue, 2019-2030
6.7.2 Turkey Melioidosis Diagnostic Market Size, 2019-2030
6.7.3 Israel Melioidosis Diagnostic Market Size, 2019-2030
6.7.4 Saudi Arabia Melioidosis Diagnostic Market Size, 2019-2030
6.7.5 UAE Melioidosis Diagnostic Market Size, 2019-2030
7 Melioidosis Diagnostic Companies Profiles
7.1 Thermo Fisher Scientific, Inc.
7.1.1 Thermo Fisher Scientific, Inc. Company Summary
7.1.2 Thermo Fisher Scientific, Inc. Business Overview
7.1.3 Thermo Fisher Scientific, Inc. Melioidosis Diagnostic Major Product Offerings
7.1.4 Thermo Fisher Scientific, Inc. Melioidosis Diagnostic Revenue in Global Market (2019-2024)
7.1.5 Thermo Fisher Scientific, Inc. Key News & Latest Developments
7.2 Bio-Rad Laboratories, Inc
7.2.1 Bio-Rad Laboratories, Inc Company Summary
7.2.2 Bio-Rad Laboratories, Inc Business Overview
7.2.3 Bio-Rad Laboratories, Inc Melioidosis Diagnostic Major Product Offerings
7.2.4 Bio-Rad Laboratories, Inc Melioidosis Diagnostic Revenue in Global Market (2019-2024)
7.2.5 Bio-Rad Laboratories, Inc Key News & Latest Developments
7.3 PerkinElmer Inc.
7.3.1 PerkinElmer Inc. Company Summary
7.3.2 PerkinElmer Inc. Business Overview
7.3.3 PerkinElmer Inc. Melioidosis Diagnostic Major Product Offerings
7.3.4 PerkinElmer Inc. Melioidosis Diagnostic Revenue in Global Market (2019-2024)
7.3.5 PerkinElmer Inc. Key News & Latest Developments
7.4 InBios International, Inc.
7.4.1 InBios International, Inc. Company Summary
7.4.2 InBios International, Inc. Business Overview
7.4.3 InBios International, Inc. Melioidosis Diagnostic Major Product Offerings
7.4.4 InBios International, Inc. Melioidosis Diagnostic Revenue in Global Market (2019-2024)
7.4.5 InBios International, Inc. Key News & Latest Developments
7.5 Mediven
7.5.1 Mediven Company Summary
7.5.2 Mediven Business Overview
7.5.3 Mediven Melioidosis Diagnostic Major Product Offerings
7.5.4 Mediven Melioidosis Diagnostic Revenue in Global Market (2019-2024)
7.5.5 Mediven Key News & Latest Developments
7.6 Cell Signaling Technology, Inc
7.6.1 Cell Signaling Technology, Inc Company Summary
7.6.2 Cell Signaling Technology, Inc Business Overview
7.6.3 Cell Signaling Technology, Inc Melioidosis Diagnostic Major Product Offerings
7.6.4 Cell Signaling Technology, Inc Melioidosis Diagnostic Revenue in Global Market (2019-2024)
7.6.5 Cell Signaling Technology, Inc Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Melioidosis Diagnostic Market Opportunities & Trends in Global Market
Table 2. Melioidosis Diagnostic Market Drivers in Global Market
Table 3. Melioidosis Diagnostic Market Restraints in Global Market
Table 4. Key Players of Melioidosis Diagnostic in Global Market
Table 5. Top Melioidosis Diagnostic Players in Global Market, Ranking by Revenue (2023)
Table 6. Global Melioidosis Diagnostic Revenue by Companies, (US$, Mn), 2019-2024
Table 7. Global Melioidosis Diagnostic Revenue Share by Companies, 2019-2024
Table 8. Global Companies Melioidosis Diagnostic Product Type
Table 9. List of Global Tier 1 Melioidosis Diagnostic Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Melioidosis Diagnostic Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global Melioidosis Diagnostic Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Melioidosis Diagnostic Revenue in Global (US$, Mn), 2019-2024
Table 13. By Type - Melioidosis Diagnostic Revenue in Global (US$, Mn), 2025-2030
Table 14. By Application ? Global Melioidosis Diagnostic Revenue, (US$, Mn), 2023 & 2030
Table 15. By Application - Melioidosis Diagnostic Revenue in Global (US$, Mn), 2019-2024
Table 16. By Application - Melioidosis Diagnostic Revenue in Global (US$, Mn), 2025-2030
Table 17. By Region ? Global Melioidosis Diagnostic Revenue, (US$, Mn), 2023 & 2030
Table 18. By Region - Global Melioidosis Diagnostic Revenue (US$, Mn), 2019-2024
Table 19. By Region - Global Melioidosis Diagnostic Revenue (US$, Mn), 2025-2030
Table 20. By Country - North America Melioidosis Diagnostic Revenue, (US$, Mn), 2019-2024
Table 21. By Country - North America Melioidosis Diagnostic Revenue, (US$, Mn), 2025-2030
Table 22. By Country - Europe Melioidosis Diagnostic Revenue, (US$, Mn), 2019-2024
Table 23. By Country - Europe Melioidosis Diagnostic Revenue, (US$, Mn), 2025-2030
Table 24. By Region - Asia Melioidosis Diagnostic Revenue, (US$, Mn), 2019-2024
Table 25. By Region - Asia Melioidosis Diagnostic Revenue, (US$, Mn), 2025-2030
Table 26. By Country - South America Melioidosis Diagnostic Revenue, (US$, Mn), 2019-2024
Table 27. By Country - South America Melioidosis Diagnostic Revenue, (US$, Mn), 2025-2030
Table 28. By Country - Middle East & Africa Melioidosis Diagnostic Revenue, (US$, Mn), 2019-2024
Table 29. By Country - Middle East & Africa Melioidosis Diagnostic Revenue, (US$, Mn), 2025-2030
Table 30. Thermo Fisher Scientific, Inc. Company Summary
Table 31. Thermo Fisher Scientific, Inc. Melioidosis Diagnostic Product Offerings
Table 32. Thermo Fisher Scientific, Inc. Melioidosis Diagnostic Revenue (US$, Mn) & (2019-2024)
Table 33. Thermo Fisher Scientific, Inc. Key News & Latest Developments
Table 34. Bio-Rad Laboratories, Inc Company Summary
Table 35. Bio-Rad Laboratories, Inc Melioidosis Diagnostic Product Offerings
Table 36. Bio-Rad Laboratories, Inc Melioidosis Diagnostic Revenue (US$, Mn) & (2019-2024)
Table 37. Bio-Rad Laboratories, Inc Key News & Latest Developments
Table 38. PerkinElmer Inc. Company Summary
Table 39. PerkinElmer Inc. Melioidosis Diagnostic Product Offerings
Table 40. PerkinElmer Inc. Melioidosis Diagnostic Revenue (US$, Mn) & (2019-2024)
Table 41. PerkinElmer Inc. Key News & Latest Developments
Table 42. InBios International, Inc. Company Summary
Table 43. InBios International, Inc. Melioidosis Diagnostic Product Offerings
Table 44. InBios International, Inc. Melioidosis Diagnostic Revenue (US$, Mn) & (2019-2024)
Table 45. InBios International, Inc. Key News & Latest Developments
Table 46. Mediven Company Summary
Table 47. Mediven Melioidosis Diagnostic Product Offerings
Table 48. Mediven Melioidosis Diagnostic Revenue (US$, Mn) & (2019-2024)
Table 49. Mediven Key News & Latest Developments
Table 50. Cell Signaling Technology, Inc Company Summary
Table 51. Cell Signaling Technology, Inc Melioidosis Diagnostic Product Offerings
Table 52. Cell Signaling Technology, Inc Melioidosis Diagnostic Revenue (US$, Mn) & (2019-2024)
Table 53. Cell Signaling Technology, Inc Key News & Latest Developments
List of Figures
Figure 1. Melioidosis Diagnostic Segment by Type in 2023
Figure 2. Melioidosis Diagnostic Segment by Application in 2023
Figure 3. Global Melioidosis Diagnostic Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Melioidosis Diagnostic Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Melioidosis Diagnostic Revenue, 2019-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Melioidosis Diagnostic Revenue in 2023
Figure 8. By Type - Global Melioidosis Diagnostic Revenue Market Share, 2019-2030
Figure 9. By Application - Global Melioidosis Diagnostic Revenue Market Share, 2019-2030
Figure 10. By Type - Global Melioidosis Diagnostic Revenue, (US$, Mn), 2023 & 2030
Figure 11. By Type - Global Melioidosis Diagnostic Revenue Market Share, 2019-2030
Figure 12. By Application - Global Melioidosis Diagnostic Revenue, (US$, Mn), 2023 & 2030
Figure 13. By Application - Global Melioidosis Diagnostic Revenue Market Share, 2019-2030
Figure 14. By Region - Global Melioidosis Diagnostic Revenue Market Share, 2019-2030
Figure 15. By Country - North America Melioidosis Diagnostic Revenue Market Share, 2019-2030
Figure 16. US Melioidosis Diagnostic Revenue, (US$, Mn), 2019-2030
Figure 17. Canada Melioidosis Diagnostic Revenue, (US$, Mn), 2019-2030
Figure 18. Mexico Melioidosis Diagnostic Revenue, (US$, Mn), 2019-2030
Figure 19. By Country - Europe Melioidosis Diagnostic Revenue Market Share, 2019-2030
Figure 20. Germany Melioidosis Diagnostic Revenue, (US$, Mn), 2019-2030
Figure 21. France Melioidosis Diagnostic Revenue, (US$, Mn), 2019-2030
Figure 22. U.K. Melioidosis Diagnostic Revenue, (US$, Mn), 2019-2030
Figure 23. Italy Melioidosis Diagnostic Revenue, (US$, Mn), 2019-2030
Figure 24. Russia Melioidosis Diagnostic Revenue, (US$, Mn), 2019-2030
Figure 25. Nordic Countries Melioidosis Diagnostic Revenue, (US$, Mn), 2019-2030
Figure 26. Benelux Melioidosis Diagnostic Revenue, (US$, Mn), 2019-2030
Figure 27. By Region - Asia Melioidosis Diagnostic Revenue Market Share, 2019-2030
Figure 28. China Melioidosis Diagnostic Revenue, (US$, Mn), 2019-2030
Figure 29. Japan Melioidosis Diagnostic Revenue, (US$, Mn), 2019-2030
Figure 30. South Korea Melioidosis Diagnostic Revenue, (US$, Mn), 2019-2030
Figure 31. Southeast Asia Melioidosis Diagnostic Revenue, (US$, Mn), 2019-2030
Figure 32. India Melioidosis Diagnostic Revenue, (US$, Mn), 2019-2030
Figure 33. By Country - South America Melioidosis Diagnostic Revenue Market Share, 2019-2030
Figure 34. Brazil Melioidosis Diagnostic Revenue, (US$, Mn), 2019-2030
Figure 35. Argentina Melioidosis Diagnostic Revenue, (US$, Mn), 2019-2030
Figure 36. By Country - Middle East & Africa Melioidosis Diagnostic Revenue Market Share, 2019-2030
Figure 37. Turkey Melioidosis Diagnostic Revenue, (US$, Mn), 2019-2030
Figure 38. Israel Melioidosis Diagnostic Revenue, (US$, Mn), 2019-2030
Figure 39. Saudi Arabia Melioidosis Diagnostic Revenue, (US$, Mn), 2019-2030
Figure 40. UAE Melioidosis Diagnostic Revenue, (US$, Mn), 2019-2030
Figure 41. Thermo Fisher Scientific, Inc. Melioidosis Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 42. Bio-Rad Laboratories, Inc Melioidosis Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 43. PerkinElmer Inc. Melioidosis Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 44. InBios International, Inc. Melioidosis Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 45. Mediven Melioidosis Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 46. Cell Signaling Technology, Inc Melioidosis Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
